Higgins Jack
Chief Scientific Officer
Sale 10b5-1
- Shares
- 13,200
- Price
- $25.32
- Value
- $334,224
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•45 filings
IMNM
Immunome Inc.
Net sales of $5.7M over the last 3 months
3 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 4 CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$5,747,142
0 buyers · 3 sellers
12-month purchases
$2,305,990
3 distinct insiders
12-month sales
$27,508,461
7 distinct insiders
Highlighted alerts
15
24 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
4 executive purchases found
Get IMNM insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
IMNM overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
95
Raw transactions
Everything returned by the filing
39
Voluntary view
P/S trades after deterministic checks
56
Administrative noise
Stored, never alerted
43
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- G
- Shares
- 8,800
- Price
- $0.00
- Footnotes
- 3
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025. The Reporting Person serves as a custodian of a custodial account for his child pursuant to the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose. 25% of the shares subject to the options vested on May 1, 2023, and one-thirty-sixth (1/36th) of the remaining shares subject to the options vests every month thereafter, subject to the Reporting Person's continuous service through each such vesting date.
Raspberry interpretation
Informational — no alert
Reason: administrative_code. The trade is reported under a Rule 10b5-1 plan.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Barchas Isaac
Director
Sale 10b5-1
- Shares
- 11,048
- Price
- $27.25
- Value
- $301,058
Barchas Isaac
Director
Sale 10b5-1
- Shares
- 62,291
- Price
- $26.23
- Value
- $1,633,893
Barchas Isaac
Director
Sale 10b5-1
- Shares
- 10,125
- Price
- $26.07
- Value
- $263,959
Barchas Isaac
Director
Sale 10b5-1
- Shares
- 15,248
- Price
- $26.06
- Value
- $397,363
Barchas Isaac
Director
Sale 10b5-1
- Shares
- 20,840
- Price
- $26.06
- Value
- $543,090
Horn Kinney
CHIEF BUSINESS OFFICER
Sale 10b5-1
- Shares
- 90,616
- Price
- $25.09
- Value
- $2,273,555
Horn Kinney
CHIEF BUSINESS OFFICER
Sale 10b5-1
- Shares
- 1,092
- Price
- $25.00
- Value
- $27,300
Barchas Isaac
Director
Sale 10b5-1
- Shares
- 16,906
- Price
- $24.20
- Value
- $409,125
Barchas Isaac
Director
Sale 10b5-1
- Shares
- 83,094
- Price
- $24.11
- Value
- $2,003,396
Lechleider Robert
Chief Medical Officer
Sale 10b5-1
- Shares
- 16,072
- Price
- $23.44
- Value
- $376,728
Lechleider Robert
Chief Medical Officer
Sale 10b5-1
- Shares
- 16,214
- Price
- $22.76
- Value
- $369,031
Lechleider Robert
Chief Medical Officer
Sale 10b5-1
- Shares
- 22,714
- Price
- $21.95
- Value
- $498,572
Barchas Isaac
Director
Sale 10b5-1
- Shares
- 24,335
- Price
- $23.33
- Value
- $567,736
Barchas Isaac
Director
Sale 10b5-1
- Shares
- 75,665
- Price
- $22.35
- Value
- $1,691,113
Barchas Isaac
Director
Sale 10b5-1
- Shares
- 101,050
- Price
- $21.12
- Value
- $2,134,176
Lechleider Robert
Chief Medical Officer
Sale 10b5-1
- Shares
- 14,420
- Price
- $20.66
- Value
- $297,917
Lechleider Robert
Chief Medical Officer
Sale 10b5-1
- Shares
- 40,580
- Price
- $19.56
- Value
- $793,745
Rosett Max
Chief Financial Officer
Sale 10b5-1
- Shares
- 60,000
- Price
- $18.23
- Value
- $1,093,800
BIENAIME JEAN JACQUES
Director
PurchaseAlert
- Shares
- 1,000
- Price
- $19.27
- Value
- $19,270
BIENAIME JEAN JACQUES
Director
PurchaseAlert
- Shares
- 3,500
- Price
- $19.46
- Value
- $68,110
BIENAIME JEAN JACQUES
Director
PurchaseAlert
- Shares
- 6,000
- Price
- $19.48
- Value
- $116,880
BIENAIME JEAN JACQUES
Director
SaleAlert
- Shares
- 10,000
- Price
- $19.41
- Value
- $194,100
BIENAIME JEAN JACQUES
Director
SaleAlert
- Shares
- 500
- Price
- $19.44
- Value
- $9,720
BIENAIME JEAN JACQUES
Director
PurchaseAlert
- Shares
- 5,000
- Price
- $20.70
- Value
- $103,500
Rosett Max
Chief Financial Officer
Sale 10b5-1
- Shares
- 1,344
- Price
- $22.48
- Value
- $30,213
Rosett Max
Chief Financial Officer
Sale 10b5-1
- Shares
- 63,656
- Price
- $21.91
- Value
- $1,394,703
Higgins Jack
Chief Scientific Officer
Sale 10b5-1
- Shares
- 9,438
- Price
- $21.64
- Value
- $204,238
SIEGALL CLAY B
President and CEO
PurchaseAlert
- Shares
- 25,450
- Price
- $19.67
- Value
- $500,602
WAGENHEIM PHILIP
Director
SaleAlert
- Shares
- 28,200
- Price
- $20.65
- Value
- $582,330
WAGENHEIM PHILIP
Director
SaleAlert
- Shares
- 36,800
- Price
- $20.47
- Value
- $753,296
BIENAIME JEAN JACQUES
Director
PurchaseAlert
- Shares
- 1,000
- Price
- $21.55
- Value
- $21,550
BIENAIME JEAN JACQUES
Director
PurchaseAlert
- Shares
- 1,000
- Price
- $22.12
- Value
- $22,120
SIEGALL CLAY B
President and CEO
PurchaseAlert
- Shares
- 4,729
- Price
- $21.15
- Value
- $100,018
Barchas Isaac
Director
Sale 10b5-1
- Shares
- 11,251
- Price
- $22.34
- Value
- $251,347
Barchas Isaac
Director
Sale 10b5-1
- Shares
- 371,949
- Price
- $21.72
- Value
- $8,078,732
Tsai Philip
Chief Technical Officer
PurchaseAlert
- Shares
- 10,000
- Price
- $20.49
- Value
- $204,900
SIEGALL CLAY B
President and CEO
PurchaseAlert
- Shares
- 7,278
- Price
- $20.48
- Value
- $149,053
SIEGALL CLAY B
President and CEO
PurchaseAlert
- Shares
- 46,511
- Price
- $21.50
- Value
- $999,987
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Higgins Jack Chief Scientific Officer | Sale | 13,200 | $25.32 | $334,224 | |
| Aug 12, 2026 | Barchas Isaac Director | Sale | 11,048 | $27.25 | $301,058 | |
| Aug 11, 2026 | Barchas Isaac Director | Sale | 62,291 | $26.23 | $1,633,893 | |
| Aug 10, 2026 | Barchas Isaac Director | Sale | 10,125 | $26.07 | $263,959 | |
| Aug 07, 2026 | Barchas Isaac Director | Sale | 15,248 | $26.06 | $397,363 | |
| Aug 06, 2026 | Barchas Isaac Director | Sale | 20,840 | $26.06 | $543,090 | |
| Aug 04, 2026 | Horn Kinney CHIEF BUSINESS OFFICER | Sale | 90,616 | $25.09 | $2,273,555 | |
| Jul 07, 2026 | Horn Kinney CHIEF BUSINESS OFFICER | Sale | 1,092 | $25.00 | $27,300 | |
| Jul 07, 2026 | Barchas Isaac Director | Sale | 16,906 | $24.20 | $409,125 | |
| Jul 06, 2026 | Barchas Isaac Director | Sale | 83,094 | $24.11 | $2,003,396 | |
| Jul 02, 2026 | Lechleider Robert Chief Medical Officer | Sale | 16,072 | $23.44 | $376,728 | |
| Jul 02, 2026 | Lechleider Robert Chief Medical Officer | Sale | 16,214 | $22.76 | $369,031 | |
| Jul 02, 2026 | Lechleider Robert Chief Medical Officer | Sale | 22,714 | $21.95 | $498,572 | |
| Jul 02, 2026 | Barchas Isaac Director | Sale | 24,335 | $23.33 | $567,736 | |
| Jul 02, 2026 | Barchas Isaac Director | Sale | 75,665 | $22.35 | $1,691,113 | |
| Jun 30, 2026 | Barchas Isaac Director | Sale | 101,050 | $21.12 | $2,134,176 | |
| Jun 25, 2026 | Lechleider Robert Chief Medical Officer | Sale | 14,420 | $20.66 | $297,917 | |
| Jun 25, 2026 | Lechleider Robert Chief Medical Officer | Sale | 40,580 | $19.56 | $793,745 | |
| Jun 15, 2026 | Rosett Max Chief Financial Officer | Sale | 60,000 | $18.23 | $1,093,800 | |
| Jun 05, 2026 | BIENAIME JEAN JACQUES Director | Purchase | 1,000 | $19.27 | $19,270 | |
| Jun 05, 2026 | BIENAIME JEAN JACQUES Director | Purchase | 3,500 | $19.46 | $68,110 | |
| Jun 05, 2026 | BIENAIME JEAN JACQUES Director | Purchase | 6,000 | $19.48 | $116,880 | |
| Jun 05, 2026 | BIENAIME JEAN JACQUES Director | Sale | 10,000 | $19.41 | $194,100 | |
| Jun 05, 2026 | BIENAIME JEAN JACQUES Director | Sale | 500 | $19.44 | $9,720 | |
| May 15, 2026 | BIENAIME JEAN JACQUES Director | Purchase | 5,000 | $20.70 | $103,500 | |
| Apr 02, 2026 | Rosett Max Chief Financial Officer | Sale | 1,344 | $22.48 | $30,213 | |
| Apr 02, 2026 | Rosett Max Chief Financial Officer | Sale | 63,656 | $21.91 | $1,394,703 | |
| Apr 02, 2026 | Higgins Jack Chief Scientific Officer | Sale | 9,438 | $21.64 | $204,238 | |
| Mar 27, 2026 | SIEGALL CLAY B President and CEO | Purchase | 25,450 | $19.67 | $500,602 | |
| Mar 23, 2026 | WAGENHEIM PHILIP Director | Sale | 28,200 | $20.65 | $582,330 | |
| Mar 20, 2026 | WAGENHEIM PHILIP Director | Sale | 36,800 | $20.47 | $753,296 | |
| Mar 11, 2026 | BIENAIME JEAN JACQUES Director | Purchase | 1,000 | $21.55 | $21,550 | |
| Mar 10, 2026 | BIENAIME JEAN JACQUES Director | Purchase | 1,000 | $22.12 | $22,120 | |
| Dec 30, 2025 | SIEGALL CLAY B President and CEO | Purchase | 4,729 | $21.15 | $100,018 | |
| Dec 22, 2025 | Barchas Isaac Director | Sale | 11,251 | $22.34 | $251,347 | |
| Dec 22, 2025 | Barchas Isaac Director | Sale | 371,949 | $21.72 | $8,078,732 | |
| Dec 19, 2025 | Tsai Philip Chief Technical Officer | Purchase | 10,000 | $20.49 | $204,900 | |
| Dec 19, 2025 | SIEGALL CLAY B President and CEO | Purchase | 7,278 | $20.48 | $149,053 | |
| Dec 18, 2025 | SIEGALL CLAY B President and CEO | Purchase | 46,511 | $21.50 | $999,987 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.